top of page

Highlighted Publications

Kedmi, R., et. al. (2022). Nature
 

Kedmi, R., Littman, R.D.,  (2024). Immunity

Rudnitsky, A., et.al. (2024). BioRxiv.

Full list of Publications

Research papers

Rudnitsky, A., Oh, H., Talmor, J., & Kedmi, R. (2024). Coordinated network of T cells and antigen presenting cells regulate tolerance to food. 

Kedmi, R., Najar, T. A., Mesa, K. R., Grayson, A., Kroehling, L., Hao, Y., ... & Littman, D. R. (2022). A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation. Nature, 610(7933), 737-7
 

Sano, T., Kageyama, T., Fang, V., Kedmi, R., Martinez, C. S., Talbot, J., ... & Littman, D. R. (2021). Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes. Cell reports, 36(8), 109608.

Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., ... & Peer, D. (2020). CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Science advances, 6(47), eabc9450.

 

Veiga, N., Goldsmith, M., Granot, Y., Rosenblum, D., Dammes, N., Kedmi, R., ... & Peer, D. (2018). Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nature communications, 9(1), 1-9.
 

Kedmi, R*., Veiga, N*., Ramishetti, S., Goldsmith, M., Rosenblum, D., Dammes, N., ... & Peer, D. (2018). A modular platform for targeted RNAi therapeutics. Nature nanotechnology, 13(3), 214-219.

*-co-first authors

 

Ramishetti, S.*, Kedmi, R.*, Goldsmith, M., Leonard, F., Sprague, A. G., Godin, B., ... & Peer, D. (2015). Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles. ACS nano, 9(7), 6706-6716.

*-co-first authors

 

Dahan, L., Huang, L., Kedmi, R., Behlke, M. A., & Peer, D. (2013). SNP detection in mRNA in living cells using allele specific FRET probes. PloS one, 8(9), e72389.
 

Bahat, A.*, Kedmi, R.*, Gazit, K., Richardo‐Lax, I., Ainbinder, E., & Dikstein, R. (2013). TAF 4b and TAF 4 differentially regulate mouse embryonic stem cells maintenance and proliferation. Genes to Cells, 18(3), 225-237.

*-co-first authors

 

Kedmi, R.*, Ben-Arie, N.*, & Peer, D. (2010). The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials, 31(26), 6867-6875.

*-co-first authors

Review papers

Kedmi, R., & Littman, R.D. (2024). Antigen-presenting cells as specialized drivers of intestinal T cell functions. Immunity Oct 8;57(10):2269-2279.

Kedmi, R., & Peer, D. (2016). Zooming in on selectins in cancer. Sci. Transl. Med, 8, 345fs311.
 

Ben-Arie, N.*, Kedmi, R.*, & Peer, D. (2011). Integrin-targeted nanoparticles for siRNA delivery. In Integrin and Cell Adhesion Molecules (pp. 497-507). Humana Press, Totowa, NJ.
*-co-first authors

 

Kedmi, R., & Peer, D. (2009). RNAi nanoparticles in the service of personalized medicine. Nanomedicine, 4(8), 853-855.

bottom of page